President Donald Trump’s administration pressed forward with plans to impose tariffs on semiconductor and pharmaceutical ...

Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s ...

USA News Group News Commentary – Routine medical appointments or cancer screening rates—an important aspect in increasing ...

The pharmaceutical company will build six new production sites and one for research and development in the USA. This will ...

Swiss pharmaceutical giant Novartis announced it will spend $23 billion to build and expand 10 facilities in the United States, including a research hub in San Diego, as it grapples with renewed ...

Novartis expects the new capacity will allow it to produce all of its key medicines “end to end” in the U.S., as the Trump ...

Find out what makes Basel's biotech hub so successful, as it has cemented its place as one of Europe's brightest life ...

Swiss pharma giant Novartis (NOVN: VX) has announced a planned $23 billion investment over five years in US-based ...

Swiss pharmaceutical company Novartis plans to invest a total of $23 billion (CHF18.75 billion) in the US over the next five ...

The pharmaceutical company says it will continue to operate its production facility near Research Triangle Park.

US-USA-TRUMP-TARIFFS-PHARMACEUTICALS:European, Indian pharma stocks decline after Trump again threatens tariffs ...

The Republican president has previously threatened import taxes on goods like copper, lumber and pharmaceutical drugs - all of which are currently exempt from Trump's "reciprocal" levies.